Allarity Therapeutics, Inc. (ALLR) has released an update to notify the public and investors about its officers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On January 27, 2024, Mr. James G. Cullem resigned from the Board of Directors, citing injurious actions by the Chairman and other directors towards the company, stockholders, and creditors. His resignation followed his prior termination as Chief Executive Officer and from all other officer positions for “cause,” which he contests should be “without cause.” The company disagrees with Cullem’s claims and has provided him the chance to respond to their statements, with any response to be filed with the U.S. Securities and Exchange Commission.
For further insights into ALLR corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.